Vertex Pharmaceuticals Incorporated (VRTX.MX)

9,360.00

0.00

(0.00%)

As of April 21 at 12:57:20 PM CST. Market Open.

Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday

Vertex Pharmaceuticals (NASDAQ: VRTX) had a fine Tuesday on the stock exchange. One of these two impactful publications was issued by Swiss bank UBS analyst Eliana Merle. The second of the pair was part of a broader dive into the current state of pharmaceutical stocks by investment bank Cantor Fitzgerald.

Motley Fool 16 hours ago

VRTX

^GSPC
3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold

When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects. Three Fool.com contributors believe they've identified relatively safe growth stocks in the healthcare sector that you can buy and hold. Here's why they picked Amgen (NASDAQ: AMGN), Eli Lilly (NYSE: LLY), and Vertex Pharmaceuticals (NASDAQ: VRTX).

Motley Fool yesterday

VRTX

LLY

AMGN
Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Zacks yesterday

VRTX

CAH
Fed Chairman Jerome Powell Warns Trump's Tariffs Could Cause Stagflation: 3 Stocks to Buy and Hold if He's Right

President Trump isn't a fan of Fed Chairman Jerome Powell, despite nominating Powell to replace Janet Yellen in 2017. Trump recently called Powell a "major loser" on a social media post and demanded that he lower interest rates immediately. On the other hand, Powell doesn't appear to be a fan of Trump's economic policies, either.

Motley Fool yesterday

VRTX

KR

D
Vertex Pharmaceuticals (NasdaqGS:VRTX) Faces UK Patent Lawsuit Over Groundbreaking CASGEVY Therapy

Vertex Pharmaceuticals (NasdaqGS:VRTX) saw its share price rise by approximately 14% in the last quarter, a significant move considering the broader market's recent 1% decline. The company's legal challenges, such as the patent infringement lawsuit filed by ToolGen Inc., could have influenced investor sentiment, highlighting the competitive tensions in the biotech sector. Furthermore, the recent European label expansion for KAFTRIO and advancements in its Type 1 diabetes portfolio may have...

Simply Wall St. yesterday

VRTX
Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next

Equity markets have been seesawing for the past two weeks. Stocks fell hard after President Donald Trump announced his tariff plans, then bounced back big once he said he would pause expanded tariffs on imported goods from most countries for 90 days. It's hard to predict which way major indexes will move next, but amid all this volatility, it helps to buy shares of companies that are likely to perform well in the long run.

Motley Fool 5 days ago

VRTX

VEEV
Stock Market Whiplash: 3 Growth Stocks That Are No-Brainer Buys on the Bounce

On one hand, it's understandable that Amazon's (NASDAQ: AMZN) share price fell as much as 29% below its previous high during the recent market sell-off. After all, the company's e-commerce revenue could be at risk if tariffs lead to an economic decline that causes consumer spending to sink. On the other hand, I'd argue that Amazon is more insulated from a faltering economy than meets the eye.

Motley Fool 8 days ago

AMZN

VRTX

META
April 2025's Stocks That May Be Priced Below Their Estimated Value

As the U.S. stock market navigates a period of heightened volatility, with major indexes experiencing significant fluctuations amid tariff discussions and economic uncertainties, investors are keenly observing opportunities that may arise from these turbulent conditions. In such an environment, identifying stocks that appear to be undervalued can offer potential value, as they might be trading below their estimated worth due to broader market pressures rather than company-specific issues.

Simply Wall St. 8 days ago

SE

VRT

VRTX
Exploring 3 High Growth Tech Stocks In The US Market

The United States market has experienced a notable uplift, climbing by 5.8% over the past week and showing a 4.8% increase over the last year, with earnings projected to grow by 14% annually in the coming years. In this environment, identifying high-growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability to capitalize on these favorable market trends.

Simply Wall St. 9 days ago

VRTX

GLW

SNPS
Nasdaq Market Whiplash: 3 Stocks to Buy Hand Over Fist and Hold for Decades

Only a few days ago, the Nasdaq was in a bear market (down 20%-plus from recent all-time highs). What should investors who are experiencing Nasdaq market whiplash do now? Alphabet is now quite reasonably valued with a price-to-earnings-to-growth (PEG) ratio of 1.04, based on data from LSEG.

Motley Fool 11 days ago

GOOG

COMP

ISRG
Vertex Researcher, Paul Negulescu Ph.D., Receives the 2025 Canada Gairdner International Award for Pioneering Research and Discovery of Medicines for Cystic Fibrosis

BOSTON, April 11, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Paul Negulescu, Ph.D. Senior Vice President, Vertex has been awarded the 2025 Canada Gairdner International Award "for pioneering research into the cellular and molecular mechanisms underlying the genetic disease cystic fibrosis, leading to the development of transformative drug therapies based on these mechanisms, thereby improving and saving countless lives." Negulescu shares the award with Michael

Business Wire 12 days ago

VRTX
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

Vertex Pharmaceuticals (NASDAQ: VRTX) is a great example of biotech success. It recently won approval for a non-opioid pain treatment that could be a game-changer for both patients and the company down the road. Of course, Vertex's success didn't happen overnight -- and the company even had to quickly shift focus after its initial drug, a hepatitis C treatment, didn't deliver lasting growth.

Motley Fool 12 days ago

CRSP

VRTX
Vertex Pharmaceuticals (VRTX) Stock Moves -1.41%: What You Should Know

Vertex Pharmaceuticals (VRTX) reachead $475.49 at the closing of the latest trading day, reflecting a -1.41% change compared to its last close.

Zacks 12 days ago

VRTX

^GSPC
Vertex Pharmaceuticals (VRTX) Surged on Increased Demand for its Cystic Fibrosis (CF) Franchise

GreensKeeper Asset Management, an investment management company, released its first quarter 2025 investor letter. A copy of the letter can be downloaded here. Markets had a difficult start to 2025; with high levels of volatility in all of the main indices. The Value Fund finished the first quarter +3.0% net of fees and expenses net […]

Insider Monkey 13 days ago

VRTX
We're About to Find Out the Answer to Warren Buffett's Pointed Question About Trump's Tariffs. Here Are 3 Stocks to Buy Depending on What That Answer Is.

Contrary to what you might read on social media, Warren Buffett isn't a fan of tariffs. Berkshire Hathaway even recently took the unusual step of issuing a press release refuting social media claims that Buffett applauded President Trump's economic policies. In an interview with CBS News in March, Buffett called tariffs an "act of war."

Motley Fool 13 days ago

VRTX

AMZN

GOLD
5 Top Growth Stocks to Buy in the Stock Market Sell-Off

Equity markets may be struggling because of President Donald Trump's current economic policies, but that doesn't mean investors should avoid buying stocks right now -- quite the contrary. History tells us that equities tend to experience strong runs following downturns, so it's worth putting money into excellent companies that are being dragged down with along with the broader market. To that end, let's consider five excellent growth-oriented companies to invest in on the dip: Novo Nordisk (NYSE: NVO), Eli Lilly (NYSE: LLY), Vertex Pharmaceuticals (NASDAQ: VRTX), Intuitive Surgical (NASDAQ: ISRG), and Shopify (NASDAQ: SHOP).

Motley Fool 14 days ago

NVO

SHOP

VRTX
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Vertex (VRTX). This makes it worthwhile to examine what the stock has in store.

Zacks 14 days ago

VRTX
An Intrinsic Calculation For Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Suggests It's 41% Undervalued

Key Insights Vertex Pharmaceuticals' estimated fair value is US$797 based on 2 Stage Free Cash Flow to Equity Current...

Simply Wall St. 14 days ago

VRTX
Jim Cramer Calls Vertex Pharmaceuticals Incorporated (VRTX) “Terrific” With “Revolutionary Pain Drug”

We recently published a list of Jim Cramer Nailed These 11 Stock Picks. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other stocks that Jim Cramer discusses. On Thursday, April 3rd, the host of Mad Money opened the most recent show by addressing the growing concerns […]

Insider Monkey 14 days ago

VRTX
Is Vertex Pharmaceuticals Incorporated (VRTX) the Best Long Term Growth Stock to Buy According to Billionaires?

We recently published a list of 10 Best Long Term Growth Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other best long term growth stocks to buy according to billionaires. As per Barclays, the US administration announced numerous executive orders […]

Insider Monkey 14 days ago

VRTX

Performance Overview

Return	VRTX.MX	S&P 500 (^GSPC)
YTD	+12.11%	-7.47%
1-Year	+40.20%	+7.33%
3-Year	+68.19%	+27.40%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Live

Vertex Pharmaceuticals Incorporated (VRTX.MX)

Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday

3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Fed Chairman Jerome Powell Warns Trump's Tariffs Could Cause Stagflation: 3 Stocks to Buy and Hold if He's Right

Vertex Pharmaceuticals (NasdaqGS:VRTX) Faces UK Patent Lawsuit Over Groundbreaking CASGEVY Therapy

Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next

Stock Market Whiplash: 3 Growth Stocks That Are No-Brainer Buys on the Bounce

April 2025's Stocks That May Be Priced Below Their Estimated Value

Exploring 3 High Growth Tech Stocks In The US Market

Nasdaq Market Whiplash: 3 Stocks to Buy Hand Over Fist and Hold for Decades

Vertex Researcher, Paul Negulescu Ph.D., Receives the 2025 Canada Gairdner International Award for Pioneering Research and Discovery of Medicines for Cystic Fibrosis

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

Vertex Pharmaceuticals (VRTX) Stock Moves -1.41%: What You Should Know

Vertex Pharmaceuticals (VRTX) Surged on Increased Demand for its Cystic Fibrosis (CF) Franchise

We're About to Find Out the Answer to Warren Buffett's Pointed Question About Trump's Tariffs. Here Are 3 Stocks to Buy Depending on What That Answer Is.

5 Top Growth Stocks to Buy in the Stock Market Sell-Off

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

An Intrinsic Calculation For Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Suggests It's 41% Undervalued

Jim Cramer Calls Vertex Pharmaceuticals Incorporated (VRTX) “Terrific” With “Revolutionary Pain Drug”

Is Vertex Pharmaceuticals Incorporated (VRTX) the Best Long Term Growth Stock to Buy According to Billionaires?

Performance Overview